Kevin Jude
Overview
Explore the profile of Kevin Jude including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
450
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sockolosky J, Trotta E, Parisi G, Picton L, Su L, Le A, et al.
Science
. 2018 Mar;
359(6379):1037-1042.
PMID: 29496879
Interleukin-2 (IL-2) is a cytokine required for effector T cell expansion, survival, and function, especially for engineered T cells in adoptive cell immunotherapy, but its pleiotropy leads to simultaneous stimulation...
2.
Weiskopf K, Jahchan N, Schnorr P, Cristea S, Ring A, Maute R, et al.
J Clin Invest
. 2016 Jun;
126(7):2610-20.
PMID: 27294525
Small-cell lung cancer (SCLC) is a highly aggressive subtype of lung cancer with limited treatment options. CD47 is a cell-surface molecule that promotes immune evasion by engaging signal-regulatory protein alpha...
3.
Moraga I, Richter D, Wilmes S, Winkelmann H, Jude K, Thomas C, et al.
Sci Signal
. 2015 Nov;
8(402):ra114.
PMID: 26554818
Cytokines dimerize cell surface receptors to activate signaling and regulate many facets of the immune response. Many cytokines have pleiotropic effects, inducing a spectrum of redundant and distinct effects on...
4.
Colleluori D, Reczkowski R, Emig F, Cama E, Cox J, Scolnick L, et al.
Arch Biochem Biophys
. 2005 Nov;
444(1):15-26.
PMID: 16266687
Rat liver arginase (arginase I) is potently inactivated by diethyl pyrocarbonate, with a second-order rate constant of 113M(-1)s(-1) for the inactivation process at pH 7.0, 25 degrees C. Partial protection...